Bill Summary

HB 65 Stem Cells (2019 Session)
Stem Cells: Establishes patient eligibility criteria & requirements relating to access to & use of investigational stem cell treatments; requires DOH to adopt rules; prohibits governmental interference in such treatments; requires institutional review boards to oversee treatments, keep records, & submit reports; prohibits purchase or sale of stem cells; provides penalties. Effective Date: July 1, 2019
11/29/18
HOUSE 
Filed
01/03/19
HOUSE 
Referred to Health Quality Subcommittee; Health Care Appropriations Subcommittee; Health & Human Services Committee
01/03/19
HOUSE 
Now in Health Quality Subcommittee
05/03/19
HOUSE 
Indefinitely postponed and withdrawn from consideration
05/03/19
HOUSE 
Died in Health Quality Subcommittee
0065
Filed on 11/29/18
PDF
No amendments to this bill text filed.
385.301
873.01
Research & Reports
Revenue Estimating Coverence Reports, Veto, Transmittal letters and more. Learn more.

No reports related to this bill.

Upcoming Events
Florida's most comprehensive legislative calendar. Learn more.

No events are scheduled at this time.

Press Releases
Related Press Announcements. Learn more.

No press releases related to this bill.

Features above are available to LobbyTools subscribers. Request a free demo or call (850) 915-0100 ext. 2 to learn more.